(19)
(11) EP 2 855 438 A2

(12)

(88) Date of publication A3:
06.02.2014

(43) Date of publication:
08.04.2015 Bulletin 2015/15

(21) Application number: 13798039.7

(22) Date of filing: 29.05.2013
(51) International Patent Classification (IPC): 
C07D 251/54(2006.01)
(86) International application number:
PCT/US2013/043052
(87) International publication number:
WO 2013/181217 (05.12.2013 Gazette 2013/49)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 29.05.2012 US 201213482837

(71) Applicant: Galleon Pharmaceuticals, Inc.
Horsham, PA 19044 (US)

(72) Inventors:
  • MANNION, James, C.
    Plainsboro, NJ 08536 (US)
  • DAX, Scott, L.
    Landenberg, PA 19350 (US)
  • MACINTYRE, Duncan, Euan
    Scotch Plains, NJ 07076 (US)
  • GOLDER, Francis, John
    Philadelphia, PA 19147 (US)
  • MCLEOD, James, Francis
    Hatboro, PA 19040 (US)

(74) Representative: Grünecker Patent- und Rechtsanwälte PartG mbB 
Anwaltssozietät Leopoldstrasse 4
80802 München
80802 München (DE)

   


(54) NOVEL COMPOUNDS AND COMPOSITIONS FOR TREATMENT OF BREATHING CONTROL DISORDERS OR DISEASES